Elderberry Supplements: Honest Evidence, and the Anthocyanin Number That Isn't on the Label
Be honest about elderberry: the evidence is real but small, mixed, and mostly low-certainty. A 2019 meta-analysis of 4 small RCTs (180 people) reported fewer upper-respiratory symptoms (Hawkins 2019) and a 2016 air-travel trial reported lower cold severity scores (Tiralongo 2016) — but 3 of those 4 trials were industry-funded, and the most rigorous independent trial found no benefit for confirmed influenza (Macknin 2020). Overall certainty is low to very low (Wieland 2021). And the buying catch: the marker actives are anthocyanins, but of the 12 products we track only 1 discloses an anthocyanin %.
Educational overview — not medical advice. Elderberry is a structure/function supplement, not a cold or flu treatment — if you have symptoms, see a clinician. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Ranked by disclosure, never commissions.
Start here
What elderberry is (and what actually does the work)
Elderberry is the fruit of Sambucus nigra, marketed for "immune support." The compounds researchers point to are its anthocyanins — the deep-purple flavonoid pigments the berry is rich in, and the marker actives that standardized extracts are measured against. What does not reliably tell you the dose: the total berry mass, the added vitamin C or zinc in a blend, or a five-figure "equivalent" number. And there's an upstream reason products vary so much: anthocyanin content in the raw fruit swings roughly 58-fold across cultivars and harvests (Wu 2015). That variability is exactly why a disclosed anthocyanin percentage matters — and why most labels leave you guessing (the anthocyanin label trap).
Does it work? (the short version)
Mixed, and honestly so. On the positive side, a 2019 meta-analysis pooled 4 small RCTs (180 participants) and reported fewer upper-respiratory symptoms (Hawkins 2019), and a 2016 randomized air-travel trial reported lower cold severity scores (p=0.02) with a borderline duration signal (Tiralongo 2016). The catch: 3 of the 4 pooled trials were industry-funded, and the single most methodologically independent trial — a 2020 emergency-department RCT in children with confirmed influenza — found no benefit (Macknin 2020). A 2021 systematic review rated the whole body of evidence low to very low certainty (Wieland 2021). Promising in small trials; not confirmed in the most rigorous independent test.
The one-line takeaway The evidence for elderberry is small, mixed and heavily industry-funded — and you mostly can't verify the anthocyanin dose from the bottle. Of the 12 products we track, only 1 discloses an anthocyanin % and 7 print a bare mg, an "equivalent," or a gummy figure — so shop on disclosure first, and keep expectations modest.
Two things to get right before you buy
First, safety: raw or unripe elderberries (and the leaves, stems and seeds) contain cyanogenic glycosides and can make you sick — a 1984 CDC report documented poisoning from juice made with uncooked berries (CDC 1984). Cooking removes them; the risk is in raw home preparation. And if you have an autoimmune condition, talk to your clinician first (why). Second, the label: because anthocyanins vary so much in the raw fruit, a product that discloses an anthocyanin % (or at least an extract ratio) is worth far more than a bigger "equivalent mg" number you can't verify (the comparison).
On this page
Elderberry Benefits: What the Evidence Actually Shows
Looking for a product? See the elderberry products we track, ranked by disclosure and cost per serving — only 1 of 12 discloses an anthocyanin percentage →
Cold and flu symptoms: what the studies found
This is the benefit elderberry is sold for, and it's the only one with a real body of human trials behind it — just not a strong one. A 2019 meta-analysis pooled 4 small randomized trials (180 participants total) and reported lower upper-respiratory symptom scores versus placebo (Hawkins 2019, PMID: 30670267), and a 2016 randomized trial in air travelers reported lower cold severity scores (Tiralongo 2016, PMID: 27023596). The honest caveat: 3 of the 4 trials in that meta-analysis were industry-funded, and the single most independent trial — a 2020 emergency-department study in children and adults with lab-confirmed influenza — found no difference in symptom duration (Macknin 2020, PMID: 32929634). A 2021 systematic review rated the overall evidence low to very-low certainty (Wieland 2021, PMID: 33827515). That's a real, honest split between the meta-analysis and the best single trial — not a case where one obviously outweighs the other. For the full study-by-study breakdown and the industry-funding pattern, see the elderberry research summary.
Antioxidant activity: real in the lab, unproven as a health benefit
Elderberry's marketed actives are its anthocyanins — the deep-purple flavonoid pigments that give the berry its color and that standardized extracts are measured against. Anthocyanins are well-documented antioxidants in laboratory assays, and this antioxidant/anti-inflammatory activity is the leading mechanistic theory behind elderberry's marketing. What's missing is the middle step: a trial showing that taking an elderberry product measurably raises antioxidant markers and that doing so improves a real health outcome in people. Neither the cold/flu trials above nor any trial we found isolates elderberry's antioxidant effect as the mechanism of benefit — it's a plausible story, not a demonstrated one.
There's also a practical problem if you want to buy on this claim: raw-fruit anthocyanin content varies roughly 58-fold across cultivars and harvests (Wu 2015, PMID: 27212789), and of the 12 elderberry products we track, only 1 discloses an anthocyanin percentage on the label. A big "10,000mg equivalent" number is fruit-equivalent weight, not anthocyanin content, and the two aren't proportional. See the anthocyanin label trap for what to actually look for.
Cholesterol and cardiovascular claims: essentially untested
You'll sometimes see elderberry marketed for cholesterol or heart health — the evidence for that specific claim is thin. A placebo-controlled trial gave 34 healthy volunteers a low-dose standardized elderberry extract (spray-dried powder, 10% anthocyanins) three times daily for two weeks, with 14 continuing a third week, and measured fasting and after-meal lipids. The result was a small, statistically non-significant change in total cholesterol (199 to 190 mg/dL in the elderberry group versus 192 to 196 mg/dL with placebo), no significant change in LDL oxidation resistance over three weeks, and no significant difference in postprandial (after-meal) triglyceride rise between groups (Murkovic 2004, PMID: 14749743). The authors themselves concluded the dose tested had only a minor effect and suggested a higher dose might do more — but no larger or longer follow-up trial appears to have tested that.
That's one small trial, at a low dose, with a null headline result. It doesn't rule out a cardiovascular benefit at a different dose, but it means a cholesterol or heart-health claim on an elderberry label is running well ahead of what's actually been shown.
Two safety lines that matter more than any benefit claim
Raw and unripe elderberries are toxic, not a "purer" version of the supplement. Raw or unripe berries, and the plant's leaves and stems, contain cyanogenic glycosides. A 1984 CDC report documented an outbreak of vomiting and diarrhea after people drank juice made from uncooked berries (PMID: 6422238). Cooking destroys these compounds, which is why commercially processed syrups, capsules, and gummies are generally regarded as lower risk — the real risk sits in raw, home-prepared juice or tea.
There's a theoretical, and partly documented, autoimmune caution. Because elderberry is marketed as an immune stimulant, there's a plausible concern for people with autoimmune disease or on immunosuppressant medication. The human evidence is limited but not nothing — a case report linked an elderberry product to autoimmune hepatitis (Ramachandran 2022, PMID: 35602846), and a later study looked at immunostimulatory herbal supplement use among autoimmune dermatology patients (Faden 2024, PMID: 39233452). A case report and an observational study are not proof of cause, but if you have an autoimmune condition or take immune-modulating medication, that's a reason to talk to a clinician before adding elderberry — full detail in the elderberry research summary.
Elderberry claims and what studies show
| Claimed benefit | Evidence grade | What the evidence shows | Caveat |
|---|---|---|---|
| Cold/flu symptom studies | Low to very-low certainty | Small trials positive (Hawkins 2019 meta, Tiralongo 2016); the independent trial found no benefit (Macknin 2020) | 3 of 4 pooled positive trials were industry-funded |
| Antioxidant / anti-inflammatory activity | Established in lab, unproven clinically | Anthocyanins are documented antioxidants in vitro; no trial isolates this as the mechanism of a human benefit | Anthocyanin content varies ~58× by cultivar and is rarely disclosed |
| Cholesterol / heart health | Essentially untested | One small RCT, low dose, found no significant change in cholesterol vs. placebo | Single trial; a higher dose has never been tested |
| Daily use | Processed products only | Commercial cooked products are generally regarded as lower risk; raw berries/leaves/stems caused a real poisoning outbreak | Home preparations from raw fruit carry genuine risk |
Does Elderberry Work for Colds and Flu? The Honest, Mixed Evidence
What the trials show — and where they stop
Read the positive trials alongside the honest null. These asked overlapping questions with different products and different funding:
| Study | Design | Finding | The honest limit |
|---|---|---|---|
| Hawkins 2019 (meta-analysis) PMID 30670267 | Pooled 4 RCTs, 180 participants total | Lower upper-respiratory symptom scores vs placebo | 3 of the 4 pooled trials were industry-funded; all small — a favorable but fragile base |
| Tiralongo 2016 (RCT) PMID 27023596 | Air-travellers, standardized extract capsules | Lower cold severity score (p=0.02); duration borderline (p=0.05); episode count NS | Industry-funded; the strongest single positive signal, but a soft duration result |
| Zakay-Rones 2004 (RCT) PMID 15080016 | Influenza, Sambucol syrup, n=60 | Symptom scores improved a few days earlier vs placebo | Small, dated, industry-funded — hypothesis-generating, not definitive |
| Macknin 2020 (RCT) — the key counter PMID 32929634 | Independent ER trial, confirmed influenza, ages 5+ | No difference in symptom duration (p=0.57) | The most methodologically independent trial — and it was null; a possible signal of longer illness was not significant |
Read together: small, mostly industry-funded trials point to a modest reduction in cold symptoms, while the most rigorous independent trial found no difference in confirmed influenza. That's not a contradiction to explain away — it's the honest state of a thin evidence base.
The anchor summary The most reliable read isn't any single trial — it's the 2021 systematic review, which concluded the overall evidence for elderberry and respiratory symptoms is low to very low certainty (Wieland 2021). In plain terms: we don't yet know. A modest benefit is plausible; it's just not established. Treat elderberry as an unproven, low-cost option — and if you buy, buy on what you can verify.
Who might reasonably consider it
- Otherwise-healthy adults who want a low-cost option to try — with realistic expectations, given the mixed, low-certainty evidence (Wieland 2021).
- People who'll buy a verifiable product — a disclosed anthocyanin % (or at least an extract ratio) beats a big "equivalent" number (the label trap; the comparison).
- Not a substitute for medical care. If you are ill, see a clinician.
Be cautious or get medical advice first if you: would use raw or home-prepared berries (toxic uncooked); have an autoimmune condition (case report + observational flare signal); or are pregnant, breastfeeding, or on immune-modulating medication.
Frequently asked questions
What do trials say about elderberry and colds?
The evidence is mixed. Small trials reported fewer symptoms (Hawkins 2019 meta; Tiralongo 2016), but 3 of 4 were industry-funded and the rigorous independent trial found nothing (Macknin 2020). Overall certainty is low to very low (Wieland 2021).
What is the active ingredient in elderberry?
The marker actives are anthocyanins — the purple flavonoid pigments the berry is standardized to. They're not the total berry mass or "equivalent mg." Raw-fruit anthocyanin varies ~58× by cultivar (Wu 2015), so a disclosed % matters.
Why are raw elderberries a problem?
Raw/unripe berries, leaves and stems contain cyanogenic glycosides and can cause vomiting and diarrhea (CDC 1984). Cooking removes them.
Why is comparing products so hard?
The number that matters — anthocyanin content — is almost never printed. Only 1 of 12 products discloses an anthocyanin %, so ranking by disclosure tier is more honest than ranking by "equivalent mg."
What are the actual benefits of elderberry?
The main human trial evidence is on cold and flu symptoms, and it is low to very-low certainty (Wieland 2021) — small trials, several industry-funded, alongside an independent trial that found no benefit (Macknin 2020). Elderberry's anthocyanins are antioxidants in lab studies, but that hasn't been shown to produce a measurable health outcome in people.
Does elderberry have antioxidant benefits?
Its anthocyanins — the purple pigments elderberry is standardized to — are potent antioxidants in laboratory assays, and that's why elderberry is marketed for immune support. But lab antioxidant activity is not the same thing as a proven human health benefit, and raw-fruit anthocyanin content varies roughly 58-fold by cultivar (Wu 2015), so even the size of the dose you're getting is usually unclear from the label.
What should I know before taking elderberry daily?
Raw or unripe berries, and the plant's leaves and stems, are a problem: they contain cyanogenic glycosides and caused a documented poisoning outbreak when people drank juice made from uncooked berries (CDC 1984). If you have an autoimmune condition, are pregnant or breastfeeding, or take immune-modulating medication, talk to a clinician before daily use, since elderberry is marketed as an immune stimulant.
What do trials say about elderberry and colds?
Small trials reported fewer symptoms (Hawkins 2019 meta; Tiralongo 2016), but 3 of 4 were industry-funded and the rigorous independent trial found nothing for confirmed flu (Macknin 2020). Overall low-to-very-low certainty (Wieland 2021).
Why are the studies so mixed?
Funding, design, and product variability. The positives were small and mostly industry-funded; the independent trial was null; and products aren't standardized to a common anthocyanin content, so trials used different preparations.
Who should be cautious?
Anyone using raw/home-prepared berries (toxic uncooked; CDC 1984) and people with autoimmune conditions (Ramachandran 2022 case report; Faden 2024 flare association) — talk to your clinician first.
Related guides
- Zinc for colds — the other "immune" staple, with its own dose-and-timing evidence
- Vitamin D for immunity — where the evidence is stronger for deficiency correction
- Does elderberry work? — the honest mixed evidence and safety cautions
Sources
- Hawkins J, et al. "Black elderberry (Sambucus nigra) supplementation and upper respiratory symptoms: a meta-analysis of randomized, controlled clinical trials." Complement Ther Med. 2019. PMID: 30670267
- Tiralongo E, et al. "Elderberry supplementation in air-travellers: a randomized, double-blind placebo-controlled clinical trial." Nutrients. 2016. PMID: 27023596
- Macknin M, et al. "Elderberry extract in emergency room patients ages 5 and older: a randomized controlled trial." J Gen Intern Med. 2020. PMID: 32929634
- Wieland LS, et al. "Elderberry and viral respiratory illnesses: a systematic review." BMC Complement Med Ther. 2021. PMID: 33827515
- Wu H, et al. "Anthocyanin content variation in elderberry cultivars." Acta Hortic. 2015. PMID: 27212789
- CDC. "Poisoning from elderberry juice." MMWR Morb Mortal Wkly Rep. 1984. PMID: 6422238
- Full product dataset: /elderberry/cost-by-brand.json (CC BY 4.0).
- Ramachandran A, et al. "A Plausible Association Between the Use of Elderberry and Autoimmune Hepatitis." Cureus. 2022. PMID: 35602846
- Faden DF, et al. "Prevalence and Risk of Immunostimulatory Herbal Supplement Treatment Among Autoimmune Dermatology Patients." ACR Open Rheumatol. 2024. PMID: 39233452
- Zakay-Rones Z, et al. "Randomized study of oral elderberry extract." J Int Med Res. 2004. PMID: 15080016